Abstract: A drying apparatus dries a recording medium on which an image is formed, under a high temperature atmosphere while conveying the recording medium, the drying apparatus includes an endless conveying belt, and a roller. The conveying belt supports and conveys the recording medium in a predetermined conveyance direction. The conveying belt is wound around the roller. The roller includes a cylindrical roller body, and flange bodies fitted into both ends of the roller body. In a fitting region between the roller body and the flange body, a thermal expansion coefficient of an inside fitted portion is higher than a thermal expansion coefficient of an outside fitted portion.

Abstract: A drying apparatus includes a conveying unit, a heater unit, a casing, a lifting mechanism, and a closing member. The conveying unit supports and conveys the recording medium in a predetermined conveyance direction. The heater unit is disposed above the conveying unit, and blows a high temperature air to the conveyed recording medium. The casing houses the heater unit. The lifting mechanism is provided in the casing and supports the heater unit so as to be lifted and lowered. The closing member comes into contact with the heater unit when the heater unit is lowered, and separates a heating space below the heater unit from an internal space of the casing. The closing member is lifted and lowered within a predetermined range as the heater unit is lifted and lowered.

Abstract: A drying apparatus dries a recording medium on which an image is formed, while conveying the recording medium. The drying apparatus includes a conveying member, a heating device, and a drying chamber, and a path. The conveying member supports and conveys the recording medium in a predetermined conveyance direction. The heating device heats the recording medium conveyed by the conveying member under a high-temperature environment. The drying chamber is arranged on an upstream side of the heating device in the conveyance direction of the recording medium and pre-dries the recording medium conveyed by the conveying member. The path communicates the heating device with the drying chamber.

Abstract: A drying device dries a recording medium on which an image is formed, while conveying the recording medium. The drying apparatus includes a conveying member and a heating device. The conveying member supports and conveys the recording medium in a predetermined conveyance direction. The heating device heats the recording medium conveyed by the conveying member under a high temperature environment. The heating device includes a heater, a reflector and a lifting mechanism. The heater emits infrared ray. The reflector reflects the infrared ray emitted from the heater toward the recording medium. The lifting mechanism lifts and lowers the reflector relative to the heater to change a number of reflections of the infrared ray.

Abstract: A secondary battery includes: a positive electrode current collector; a negative electrode current collector; a positive electrode electrolytic solution part provided so as to be in contact with the positive electrode current collector, the positive electrode electrolytic solution part containing a positive electrode electrolytic solution; and a negative electrode electrolytic solution part provided so as to be in contact with the negative electrode current collector, the negative electrode electrolytic solution part containing a negative electrode electrolytic solution. The positive electrode electrolytic solution contains a positive electrode active material, an electrolyte salt, and a non-aqueous solvent containing a first solvent. The negative electrode electrolytic solution contains a negative electrode active material, an electrolyte salt, and a non-aqueous solvent containing a second solvent.

Abstract: The present invention provides a damaged part treatment composition for repairing a damaged part of a target tissue that includes a stem cell-conditioned medium obtained by culturing stem cells; a damaged part treatment method for repairing or restoring a damaged part of a target tissue that includes administering the damaged part treatment composition to a patient having the target tissue for the damaged part treatment composition in an amount therapeutically effective for repairing the damaged part of the target tissue; a method of treating cerebral infarction that includes administering the damaged part treatment composition to a cerebral infarct patient in an amount effective for repairing a damaged part of the brain; and a method of treating a CNS disease that includes administering, as a CNS disease treatment composition, the damaged part treatment composition to a CNS disease patient in a therapeutically effective amount.

Abstract: A composition having tissue repair activity, which is capable of promoting reactions associated with tissue repair, contains at least one selected from the group consisting of a first component that is a protein having a monocyte chemotactic protein-1 (MCP-1) activity, a second component that is a protein having the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and a third component that is at least one of chondroitin sulfate and chondroitin sulfate proteoglycan.

Abstract: A composition for preventing or treating inflammatory disease and that is effective for inflammatory disease such as fulminant hepatitis and interstitial pneumonia. For such an objective, the present uses a culture supernatant obtained by culturing dental pulp stem cells as the active ingredient of the composition for preventing or treating inflammatory disease.

Abstract: The invention provides a novel anticancer therapeutic having a high effect against solid cancers, lacking the side effects of chemotherapeutics, and being unlikely to cause resistance. Provided is a pharmaceutical composition for cancer treatment prepared by a method having: a stem cell production step for making immortalized stem cells by introducing four types of genes into deciduous tooth dental pulp stem cells obtained from the dental pulp of mammals; and a condition medium preparation step for culturing the immortalized stem cells for a predetermined length of time in serum-free medium at 23-27° C. under conditions of low oxygen concentration at an oxygen concentration of from 0.5% to less than 20%, the pharmaceutical composition containing 1.5 times or more of insulin-like growth factor (IGF-1) and vascular endothelial growth factor (VEGF) than is contained in condition medium prepared when culturing at an oxygen concentration of 20% and otherwise identical conditions.

Abstract: A composition having tissue repair activity, which is capable of promoting reactions associated with tissue repair, contains at least one selected from the group consisting of a first component that is a protein having a monocyte chemotactic protein-1 (MCP-1) activity, a second component that is a protein having the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and a third component that is at least one of chondroitin sulfate and chondroitin sulfate proteoglycan.

Abstract: A composition having tissue repair activity, which is capable of promoting reactions associated with tissue repair, contains at least one selected from the group consisting of a first component that is a protein having a monocyte chemotactic protein-1 (MCP-1) activity, a second component that is a protein having the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and a third component that is at least one of chondroitin sulfate and chondroitin sulfate proteoglycan.

Abstract: The purpose of the present invention is to provide immortalized stem cells, which produce a growth factor capable of regenerating various kinds of tissues that have been damaged by a variety of causes, and a method for producing the aforesaid immortalized stem cells. Another purpose is to provide a medicinal composition and a medicinal preparation for restoring damaged tissues, and a method for the percutaneous absorption of a culture supernatant. Provided are immortalized stem cells that are obtained by isolating stem cells selected from the group consisting of mammalian mesenchymal cells, an embryo at the early stage of the development and somatic cells, first culturing the cells to give first stage culture cells, transferring four kinds of genes into the first stage culture cells to give transgenic cells, and selecting the desired immortalized stem cells from among the transgenic cells using the expression of STRO-1 as an index.

Abstract: A zoom lens comprises in order from an object side, a first lens unit having a positive refractive power, a second lens unit having a negative refractive power, and a third lens unit having a positive refractive power, and the third unit having a positive refractive power comprises in order from the object side, a first lens component having a positive refractive power, and a second lens component having a negative refractive power in which, a lens having a positive refractive power and a lens having a negative refractive power are cemented, and the zoom lens satisfies the following conditional expressions (1), (2), and (3) 1.4<|f3_2p/f3_2n|<2.6??(1) nd3_2p?nd3_2n?0??(2) nd3_2n?1.8??(3).

Abstract: The present invention provides a damaged part treatment composition for repairing a damaged part of a target tissue that includes a stem cell-conditioned medium obtained by culturing stem cells; a damaged part treatment method for repairing or restoring a damaged part of a target tissue that includes administering the damaged part treatment composition to a patient having the target tissue for the damaged part treatment composition in an amount therapeutically effective for repairing the damaged part of the target tissue; a method of treating cerebral infarction that includes administering the damaged part treatment composition to a cerebral infarct patient in an amount effective for repairing a damaged part of the brain; and a method of treating a CNS disease that includes administering, as a CNS disease treatment composition, the damaged part treatment composition to a CNS disease patient in a therapeutically effective amount.

Abstract: A composition having tissue repair activity, which is capable of promoting reactions associated with tissue repair, contains at least one selected from the group consisting of a first component that is a protein having a monocyte chemotactic protein-1 (MCP-1) activity, a second component that is a protein having the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and a third component that is at least one of chondroitin sulfate and chondroitin sulfate proteoglycan.

Abstract: A zoom lens comprises in order from an object side, a first lens unit having a positive refractive power, a second lens unit having a negative refractive power, and a third lens unit having a positive refractive power, and the third unit having a positive refractive power comprises in order from the object side, a first lens component having a positive refractive power, and a second lens component having a negative refractive power in which, a lens having a positive refractive power and a lens having a negative refractive power are cemented, and the zoom lens satisfies the following conditional expressions (1), (2), and (3) 1.4<|f3_2p/f3_2n|<2.6??(1) nd3_2p?nd3_2n?0??(2) nd3_2n?1.8??(3).

Abstract: A zoom lens comprises in order from an object side, a first lens unit having a positive refractive power, a second lens unit having a negative refractive power, and a third lens unit having a positive refractive power, and the third unit having a positive refractive power comprises in order from the object side, a first lens component having a positive refractive power, and a second lens component having a negative refractive power in which, a lens having a positive refractive power and a lens having a negative refractive power are cemented, and the zoom lens satisfies the following conditional expressions (1), (2), and (3). 1.4<|f3_2p/f3_2n|<2.6??(1) nd3_2p?nd3_2n?0??(2) nd3_2n?1.8??(3).

Abstract: A composition having tissue repair activity, which is capable of promoting reactions associated with tissue repair, contains at least one selected from the group consisting of a first component that is a protein having a monocyte chemotactic protein-1 (MCP-1) activity, a second component that is a protein having the extracellular domain activity of sialic acid-binding immunoglobulin-type lectin-9 (Siglec-9), and a third component that is at least one of chondroitin sulfate and chondroitin sulfate proteoglycan.

Abstract: The purpose of the present invention is to provide immortalized stem cells, which produce a growth factor capable of regenerating various kinds of tissues that have been damaged by a variety of causes, and a method for producing the aforesaid immortalized stem cells. Another purpose is to provide a medicinal composition and a medicinal preparation for restoring damaged tissues, and a method for the percutaneous absorption of a culture supernatant. Provided are immortalized stem cells that are obtained by isolating stem cells selected from the group consisting of mammalian mesenchymal cells, an embryo at the early stage of the development and somatic cells, first culturing the cells to give first stage culture cells, transferring four kinds of genes into the first stage culture cells to give transgenic cells, and selecting the desired immortalized stem cells from among the transgenic cells using the expression of STRO-1 as an index.

Abstract: A zoom lens includes, in order from the object side, a first lens unit having a negative refractive power, a second lens unit having a positive refractive power, and a third lens unit having a positive refractive power. The first lens unit includes a negative lens and a positive lens. The zoom lens satisfies the following conditional expression (1): ?d13/ft<0.4??(1) where ?d13 is the total sum of the thickness of the lenses included in the first to third lens units of the zoom lens on the optical axis, and ft is the focal length of the entire zoom lens system at the telephoto end.